Protocol No.: IMGN853-0416

Title
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression
Principal Investigator
Galvan Turner, Valerie
Phase
III
Age Group
Adult
Applicable Disease Site
Gynecologic Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Deborah Moore, MS
Research Specialist
Phone: +1 304-293-0609

View on ClinicalTrials.gov